StockData
CLGNNasdaqOrthopedic, Prosthetic & Surgical Appliances & SuppliesFiscal year ends December 31

CollPlant Biotechnologies Ltd

Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Mar 26, 2026
$3.56−0.06 (-1.79%)

Close on Oct 19, 2026

Market cap
–
P/E (TTM)
–
Dividend yield
–

CollPlant Biotechnologies Ltd revenue by segment

No segment breakdown reported

CollPlant Biotechnologies does not break out revenue by segment, region or product in the tagged data of its filings for this period type.